Alireza Najafian
Research Subjects
Alireza Najafian has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Eric B. Schneider
Yale School of Medicine, Yale University , New Haven, Connecticut
2 shared publications - Martha A. Zeiger
Office of Surgeon Scientist Programs, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
2 shared publications Adil H. Haider
Center for Surgical Trials and Outcomes Research, Department of Surgery, The Johns Hopkins Hospital, Baltimore, Maryland; Division of Trauma and Acute Care Surgery, Department of Surgery, The Johns Hopkins Hospital, Baltimore, Maryland
1 shared publication- Bryan A. Ehlert
Division of Vascular and Endovascular Therapy, Johns Hopkins Hospital, Baltimore, MD
1 shared publication - Christopher J. Abularrage
Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA
1 shared publication Christopher M. Bono
Department of Orthopedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA
1 shared publication
Latest Publications
- 4 November 2024
- Published by Elsevier in The Spine Journal
- Vol. 25 (3) , 403-410
Back pain in patients with macromastia: what a spine surgeon should know?
- 4 November 2024
- Published by Elsevier in The Spine Journal
- Vol. 25 (3) , 403-410
Back pain in patients with macromastia: what a spine surgeon should know?
- 16 June 2016
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 32, 187-188
Reply to: Letter to the Editor on the article “Parathyroid surgery can be safely performed in a community hospital by experienced parathyroid surgeons: A retrospective cohort study”
We appreciate the opportunity to respond to the Letter to the Editor by Dr. Mayilvaganan Sabaretnam et al. regarding our recently published article, and to further clarify certain aspects of our study [ 1 x [1] Neychev, V.K., Ghanem, M., Blackwood, S.L., Han, P.A., Fazeli, R., Schneider, E. et al. Parathyroid surgery can be safely performed in a community hospital by experienced parathyroid surgeons: a retrospective cohort study. Int. J. Surg. 2016 March; 27: 72–76 Abstract | Full Text | Full Text PDF | PubMed | Scopus (2) | Google Scholar See all References ] [1] .
- 16 June 2016
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 32, 187-188
Reply to: Letter to the Editor on the article “Parathyroid surgery can be safely performed in a community hospital by experienced parathyroid surgeons: A retrospective cohort study”
We appreciate the opportunity to respond to the Letter to the Editor by Dr. Mayilvaganan Sabaretnam et al. regarding our recently published article, and to further clarify certain aspects of our study [ 1 x [1] Neychev, V.K., Ghanem, M., Blackwood, S.L., Han, P.A., Fazeli, R., Schneider, E. et al. Parathyroid surgery can be safely performed in a community hospital by experienced parathyroid surgeons: a retrospective cohort study. Int. J. Surg. 2016 March; 27: 72–76 Abstract | Full Text | Full Text PDF | PubMed | Scopus (2) | Google Scholar See all References ] [1] .
- 1 January 2016
- Published by Elsevier in Journal of Surgical Research
- Vol. 200 (1) , 356-364
Thirty-day readmission after lower extremity bypass in diabetic patients
- 1 January 2016
- Published by Elsevier in Journal of Surgical Research
- Vol. 200 (1) , 356-364
Thirty-day readmission after lower extremity bypass in diabetic patients
- 7 January 2015
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 22 (9) , 3007-3013
Clinical Presentation of Patients with a Thyroid Follicular Neoplasm: Are there Preoperative Predictors of Malignancy?
Studies examining differences in presentation of patients with benign [follicular adenoma (FA)] and malignant follicular thyroid neoplasms [follicular thyroid carcinoma (FTC) or follicular variant papillary thyroid carcinoma (FVPTC)] include only one or two of these subtypes, and none has considered clinical, cytological, and sonographic features together. We therefore examined presenting clinical features of all benign and malignant follicular neoplasm subtypes in an attempt to identify predictors of malignancy. Consecutive patients with a surgically resected follicular thyroid neoplasm at a tertiary hospital from 2005 to 2013 were reviewed. Age, gender, symptoms, history, physical findings, nodule size, sonographic, cytologic, and final pathologic results were recorded. Multivariate logistic regression was used to determine variables that contributed to a diagnosis of malignant follicular neoplasm. A total of 616 patients (163 males, 453 females) presented with 441 FAs, 17 FTCs, and 158 FVPTCs. On multivariate analysis, male sex [odds ratio (OR) 1.87, p = 0.008], family history of thyroid cancer (OR 5.16, p < 0.001), and history of head and neck radiation (OR 2.01, p = 0.04) were associated with an increased odds of malignancy; age >45 (OR 2.03, p = 0.001), dysphagia (OR 3.48, p = 0.001) or pressure sensation (OR 3.00, p = 003), concomitant hyperthyroidism (OR 4.76, p = 0.01), nodules ≥4 cm (OR 3.68, p < 0.001), and multinodularity on physical examination (OR 1.93, p = 0.004) were associated with an increased odds of a benign lesion. Independent clinical predictors exist that might be helpful in preoperative differentiation of benign and malignant follicular neoplasms. A combination of these predictors with both FNA and molecular results may help us to improve the clinical management of patients with follicular thyroid lesions.
- 7 January 2015
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 22 (9) , 3007-3013
Clinical Presentation of Patients with a Thyroid Follicular Neoplasm: Are there Preoperative Predictors of Malignancy?
Studies examining differences in presentation of patients with benign [follicular adenoma (FA)] and malignant follicular thyroid neoplasms [follicular thyroid carcinoma (FTC) or follicular variant papillary thyroid carcinoma (FVPTC)] include only one or two of these subtypes, and none has considered clinical, cytological, and sonographic features together. We therefore examined presenting clinical features of all benign and malignant follicular neoplasm subtypes in an attempt to identify predictors of malignancy. Consecutive patients with a surgically resected follicular thyroid neoplasm at a tertiary hospital from 2005 to 2013 were reviewed. Age, gender, symptoms, history, physical findings, nodule size, sonographic, cytologic, and final pathologic results were recorded. Multivariate logistic regression was used to determine variables that contributed to a diagnosis of malignant follicular neoplasm. A total of 616 patients (163 males, 453 females) presented with 441 FAs, 17 FTCs, and 158 FVPTCs. On multivariate analysis, male sex [odds ratio (OR) 1.87, p = 0.008], family history of thyroid cancer (OR 5.16, p < 0.001), and history of head and neck radiation (OR 2.01, p = 0.04) were associated with an increased odds of malignancy; age >45 (OR 2.03, p = 0.001), dysphagia (OR 3.48, p = 0.001) or pressure sensation (OR 3.00, p = 003), concomitant hyperthyroidism (OR 4.76, p = 0.01), nodules ≥4 cm (OR 3.68, p < 0.001), and multinodularity on physical examination (OR 1.93, p = 0.004) were associated with an increased odds of a benign lesion. Independent clinical predictors exist that might be helpful in preoperative differentiation of benign and malignant follicular neoplasms. A combination of these predictors with both FNA and molecular results may help us to improve the clinical management of patients with follicular thyroid lesions.